Lehmann-Masten V - Search Results

1

The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity.

Henry SA, Lehmann-Masten V, Gasparini F, Geyer MA, Markou A. Henry SA, et al. Among authors: lehmann masten v. Neuropharmacology. 2002 Dec;43(8):1199-209. doi: 10.1016/s0028-3908(02)00332-5. Neuropharmacology. 2002. PMID: 12527469

2

Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.

Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB. Halberstadt AL, et al. Among authors: lehmann masten vd. Psychopharmacology (Berl). 2011 May;215(1):81-92. doi: 10.1007/s00213-010-2115-1. Epub 2010 Dec 10. Psychopharmacology (Berl). 2011. PMID: 21153406 Free PMC article.

3

Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin.

Krebs-Thomson K, Lehmann-Masten V, Naiem S, Paulus MP, Geyer MA. Krebs-Thomson K, et al. Among authors: lehmann masten v. Eur J Pharmacol. 1998 Feb 19;343(2-3):135-43. doi: 10.1016/s0014-2999(97)01557-4. Eur J Pharmacol. 1998. PMID: 9570460

4

Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats.

Bakshi VP, Tricklebank M, Neijt HC, Lehmann-Masten V, Geyer MA. Bakshi VP, et al. Among authors: lehmann masten v. J Pharmacol Exp Ther. 1999 Feb;288(2):643-52. J Pharmacol Exp Ther. 1999. PMID: 9918570

5

Effects of LU-111995 in three models of disrupted prepulse inhibition in rats.

Geyer MA, Swerdlow NR, Lehmann-Masten V, Teschendorf HJ, Traut M, Gross G. Geyer MA, et al. Among authors: lehmann masten v. J Pharmacol Exp Ther. 1999 Aug;290(2):716-24. J Pharmacol Exp Ther. 1999. PMID: 10411583

6

Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats.

Lehmann-Masten VD, Geyer MA. Lehmann-Masten VD, et al. Neuropharmacology. 1991 Jun;30(6):629-36. doi: 10.1016/0028-3908(91)90083-n. Neuropharmacology. 1991. PMID: 1922682

7

The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.

Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA. Barr AM, et al. Among authors: lehmann masten v. Neuropsychopharmacology. 2004 Feb;29(2):221-8. doi: 10.1038/sj.npp.1300343. Neuropsychopharmacology. 2004. PMID: 14603268

8

MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.

Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA. Powell SB, et al. Among authors: lehmann masten vd. Psychopharmacology (Berl). 2004 May;173(3-4):310-7. doi: 10.1007/s00213-003-1765-7. Epub 2004 Jan 28. Psychopharmacology (Berl). 2004. PMID: 14747902

9

Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.

Ralph-Williams RJ, Lehmann-Masten V, Geyer MA. Ralph-Williams RJ, et al. Among authors: lehmann masten v. Neuropsychopharmacology. 2003 Jan;28(1):108-18. doi: 10.1038/sj.npp.1300017. Neuropsychopharmacology. 2003. PMID: 12496946

10

Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice.

Ralph-Williams RJ, Lehmann-Masten V, Otero-Corchon V, Low MJ, Geyer MA. Ralph-Williams RJ, et al. Among authors: lehmann masten v. J Neurosci. 2002 Nov 1;22(21):9604-11. doi: 10.1523/JNEUROSCI.22-21-09604.2002. J Neurosci. 2002. PMID: 12417685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters